Cargando…

microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma

ABSTRACT: Growing evidence indicates that miR-146a is involved in carcinogenesis and tumor progression in several human malignancies. However, the molecular details underlying miR-146a mediated regulation of its target genes and its precise biological function in cancer, especially in hepatocellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zheng, Zhang, Yang, Sun, Xiu-Xuan, Ma, Xi, Chen, Zhi-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326400/
https://www.ncbi.nlm.nih.gov/pubmed/25608619
http://dx.doi.org/10.1186/1476-4598-14-5
_version_ 1782356920182505472
author Zhang, Zheng
Zhang, Yang
Sun, Xiu-Xuan
Ma, Xi
Chen, Zhi-Nan
author_facet Zhang, Zheng
Zhang, Yang
Sun, Xiu-Xuan
Ma, Xi
Chen, Zhi-Nan
author_sort Zhang, Zheng
collection PubMed
description ABSTRACT: Growing evidence indicates that miR-146a is involved in carcinogenesis and tumor progression in several human malignancies. However, the molecular details underlying miR-146a mediated regulation of its target genes and its precise biological function in cancer, especially in hepatocellular carcinoma (HCC) remains unclear. METHODS: The expression levels of genes including miR-146a, APC, VEGF and HAb18G were examined in HCC cell lines and patient specimens were compared with control levels using quantitative reverse transcription-PCR. The functions of miR-146a and HAb18G in migration/invasion and liver metastasis formation were determined by transwell and spleen injection assays, respectively. miR-146a related genes were determined by PCR array. The potential regulatory targets of miR-146a were determined by bioinformatics and prediction tools, correlation with target protein expression, and luciferase reporter assay. DNA methylation status of miR-146a promoter were performed by PCR analysis of bisulfite-modified genomic DNA. RESULTS: We demonstrated that miR-146a expression was markedly downregulated in hepatoma cells and hepatoma tissues compared to immortalized normal liver epithelial cells and normal hepatic tissues. DNA methylation of miR-146a promoter correlated with its downexpression and with liver cancer metastasis. The restoration of miR-146a dramatically suppressed HCC cell invasion and metastasis by repressing VEGF expression through upregulating APC, which inhibits β-catenin accumulation in nucleus, and downregulating NF-κB p65 by targeting HAb18G. In human HCC, miR-146a expression was negative correlated with increased HAb18G, VEGF, NF-κB p65 and beneficial prognosis. CONCLUSION: This study identified a novel target of miR-146a and defined miR-146a as a crucial tumor suppressor in human HCC that acts through multiple pathways and mechanisms to suppress HCC invasion or metastasis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-4598-14-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4326400
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43264002015-02-14 microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma Zhang, Zheng Zhang, Yang Sun, Xiu-Xuan Ma, Xi Chen, Zhi-Nan Mol Cancer Research ABSTRACT: Growing evidence indicates that miR-146a is involved in carcinogenesis and tumor progression in several human malignancies. However, the molecular details underlying miR-146a mediated regulation of its target genes and its precise biological function in cancer, especially in hepatocellular carcinoma (HCC) remains unclear. METHODS: The expression levels of genes including miR-146a, APC, VEGF and HAb18G were examined in HCC cell lines and patient specimens were compared with control levels using quantitative reverse transcription-PCR. The functions of miR-146a and HAb18G in migration/invasion and liver metastasis formation were determined by transwell and spleen injection assays, respectively. miR-146a related genes were determined by PCR array. The potential regulatory targets of miR-146a were determined by bioinformatics and prediction tools, correlation with target protein expression, and luciferase reporter assay. DNA methylation status of miR-146a promoter were performed by PCR analysis of bisulfite-modified genomic DNA. RESULTS: We demonstrated that miR-146a expression was markedly downregulated in hepatoma cells and hepatoma tissues compared to immortalized normal liver epithelial cells and normal hepatic tissues. DNA methylation of miR-146a promoter correlated with its downexpression and with liver cancer metastasis. The restoration of miR-146a dramatically suppressed HCC cell invasion and metastasis by repressing VEGF expression through upregulating APC, which inhibits β-catenin accumulation in nucleus, and downregulating NF-κB p65 by targeting HAb18G. In human HCC, miR-146a expression was negative correlated with increased HAb18G, VEGF, NF-κB p65 and beneficial prognosis. CONCLUSION: This study identified a novel target of miR-146a and defined miR-146a as a crucial tumor suppressor in human HCC that acts through multiple pathways and mechanisms to suppress HCC invasion or metastasis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-4598-14-5) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-21 /pmc/articles/PMC4326400/ /pubmed/25608619 http://dx.doi.org/10.1186/1476-4598-14-5 Text en © Zhang et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhang, Zheng
Zhang, Yang
Sun, Xiu-Xuan
Ma, Xi
Chen, Zhi-Nan
microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma
title microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma
title_full microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma
title_fullStr microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma
title_full_unstemmed microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma
title_short microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma
title_sort microrna-146a inhibits cancer metastasis by downregulating vegf through dual pathways in hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326400/
https://www.ncbi.nlm.nih.gov/pubmed/25608619
http://dx.doi.org/10.1186/1476-4598-14-5
work_keys_str_mv AT zhangzheng microrna146ainhibitscancermetastasisbydownregulatingvegfthroughdualpathwaysinhepatocellularcarcinoma
AT zhangyang microrna146ainhibitscancermetastasisbydownregulatingvegfthroughdualpathwaysinhepatocellularcarcinoma
AT sunxiuxuan microrna146ainhibitscancermetastasisbydownregulatingvegfthroughdualpathwaysinhepatocellularcarcinoma
AT maxi microrna146ainhibitscancermetastasisbydownregulatingvegfthroughdualpathwaysinhepatocellularcarcinoma
AT chenzhinan microrna146ainhibitscancermetastasisbydownregulatingvegfthroughdualpathwaysinhepatocellularcarcinoma